Landon G. Vom Steeg

Landon G. Vom Steeg

Auto-generated profile, based on publicly available information

Landon G. Vom Steeg

Department of Biology and Entomology, The Pennsylvania State University, University Park, PA, 16802, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2016 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LSLandon G. Vom Steeg
Landon G. Vom Steeg
SKSabra L. Klein
Sabra L. Klein

1 February 2017 in Hormones and Behavior
Verified
Journal Article
Closed access
LSLandon G. Vom Steeg
Landon G. Vom Steeg
SKSabra L. Klein
Sabra L. Klein

8 October 2018 in Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
LSLandon G. Vom Steeg
Landon G. Vom Steeg
SKSabra L. Klein
Sabra L. Klein

1 December 2016 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
LSLandon G. Vom Steeg
Landon G. Vom Steeg
MVMeghan S. Vermillion
Meghan S. Vermillion
OHOlivia J. Hall
Olivia J. Hall
OAOrnob Alam
Ornob Alam
RMRoss McFarland
Ross McFarland
SKSabra L. Klein
Sabra L. Klein
Influenza severity increases with age, with hospitalization and mortality rates during seasonal influenza epidemics being higher in older men than age-matched women. As it is known that with age, circulating testosterone levels decline in males, we hypothesized that reduced testosterone contributes to age-associated increases in influenza severity. A murine model was used to test this hypothesis. As in men, testosterone concentrations were lower in aged (18 mo) than young (2 mo) male C57BL/6 mice. Following inoculation with influenza A virus (IAV), aged males experienced greater morbidity, clinical disease, and pulmonary inflammation than young males, and had lower neutralizing and total anti-influenza IgG antibody responses. Peak titers of virus in the lungs did not differ between aged and young males, but virus clearance was delayed in aged males. In young males, removal of the gonads increased—whereas treatment of gonadectomized males with testosterone reduced—morbidity, clinical illness, and pulmonary pathology, but viral replication was not altered by hormone manipulation in young males. Treatment of aged males with testosterone improved survival following infection but did not alter either virus replication or pulmonary pathology. These results indicate that low concentrations of testosterone, whether induced surgically in young males or naturally occurring in aged males, negatively impact the outcome of influenza.

9 July 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LSLandon G. Vom Steeg
Landon G. Vom Steeg
SDSantosh Dhakal
Santosh Dhakal
YWYishak A. Woldetsadik
Yishak A. Woldetsadik
HPHan-Sol Park
Han-Sol Park
KMKathleen R. Mulka
Kathleen R. Mulka
SKSabra L. Klein
Sabra L. Klein
Circulating androgens can modulate immune cell activity, but the impact of androgens on viral pathogenesis remains unclear. Previous data demonstrate that testosterone reduces the severity of influenza A virus (IAV) infection in male mice by mitigating pulmonary inflammation rather than by affecting viral replication. To examine the immune responses mediated by testosterone to mitigate IAV-induced inflammation, adult male mice remained gonadally intact or were gonadectomized and treated with either placebo or androgen-filled (i.e., testosterone or dihydrotestosterone) capsules prior to sublethal IAV infection. Like intact males, treatment of gonadectomized males with androgens improved the outcome of IAV infection, which was not mediated by changes in the control of virus replication or pulmonary cytokine activity. Instead, androgens accelerated pulmonary leukocyte contraction to limit inflammation. To identify which immune cells were contracting in response to androgens, the composition of pulmonary cellular infiltrates was analyzed and revealed that androgens specifically accelerated the contraction of total pulmonary inflammatory monocytes during peak disease, as well as CD8+ T cells, IAV-specific CD8+ T numbers, cytokine production and degranulation by IAV-specific CD8+ T cells, and the influx of eosinophils into the lungs following clearance of IAV. Neither depletion of eosinophils nor adoptive transfer of CD8+ T cells could reverse the ability of testosterone to protect males against IAV suggesting these were secondary immunologic effects. The effects of testosterone on the contraction of immune cell numbers and activity were blocked by co-administration of the androgen receptor antagonist flutamide and mimicked by treatment with dihydrotestosterone, which was also able to reduce the severity of IAV in female mice. These data suggest that androgen receptor signaling creates a local pulmonary environment that promotes downregulation of detrimental inflammatory immune responses to protect against prolonged influenza disease. In the United States alone, it is estimated that over 2 million men are taking testosterone replacement therapy caused by congenital, acquired, or age-associated reductions in circulating testosterone, with known immunomodulatory effects. Despite the increasing popularity of testosterone replacement therapy, the influence of testosterone deficiency and treatment on clinical outcomes of infectious disease has not been adequately considered. Disease following influenza A virus (IAV) infection is largely immune-mediated, with severe disease often associated with excessive or aberrant immune responses (i.e., a cytokine storm) to the virus. We have made the novel observation that administration of testosterone to male mice improves the outcome of IAV infection not by mitigating global pulmonary cytokine production, but by promoting the specific contraction of pulmonary inflammatory monocytes during peak disease and the frequencies of virus-specific pulmonary CD8+ T cells and eosinophils in the lungs following control of viral replication. The protective effects of testosterone on IAV pathogenesis are dependent on androgen receptor signaling, which creates a pulmonary environment conducive to reduced pulmonary inflammation. Rather than acting directly on a single cell population, androgen receptor signaling has multicellular effects and creates a local environment that promotes accelerated contraction of inflammatory immune cells. Activation of androgen receptor signaling confers protection during IAV infection by modulating the immune response, which may have therapeutic potential in both male and female patients.

17 July 2018 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
MVMeghan S. Vermillion
Meghan S. Vermillion
RURebecca L. Ursin
Rebecca L. Ursin
DKDenise I. T. Kuok
Denise I. T. Kuok
LSLandon G. Vom Steeg
Landon G. Vom Steeg
NWNicholas Wohlgemuth
Nicholas Wohlgemuth
SKSabra L. Klein
Sabra L. Klein
Amphiregulin (AREG) is an epidermal growth factor that is a significant mediator of tissue repair at mucosal sites, including in the lungs during influenza A virus (IAV) infection. Previous research illustrates that males of reproductive ages experience less severe disease and recover faster than females following infection with IAV. Whether males and females differentially produce and utilize AREG for pulmonary repair after IAV infection was investigated using murine models on a C57BL/6 background and primary mouse and human epithelial cell culture systems. Following sublethal infection with 2009 H1N1 IAV, adult female mice experienced greater morbidity and pulmonary inflammation during the acute phase of infection as well as worse pulmonary function during the recovery phase of infection than males, despite having similar virus clearance kinetics. As compared with females, AREG expression was greater in the lungs of male mice as well as in primary respiratory epithelial cells derived from mouse and human male donors, in response to H1N1 IAVs. Internalization of the epidermal growth factor receptor (EGFR) was also greater in respiratory epithelial cells derived from male than female mice. IAV infection of Areg knock-out (Areg−/−) mice eliminated sex differences in IAV pathogenesis, with a more significant role for AREG in infection of male compared to female mice. Deletion of Areg had no effect on virus replication kinetics in either sex. Gonadectomy and treatment of either wild-type or Areg−/− males with testosterone improved the outcome of IAV as compared with their placebo-treated conspecifics. Taken together, these data show that elevated levels of testosterone and AREG, either independently or in combination, improve resilience (i.e., repair and recovery of damaged tissue) and contribute to better influenza outcomes in males compared with females.